Dermatological phenotype in Costello syndrome: Consequences of Ras dysregulation in development

D. H. Siegel, J. A. Mann, A. L. Krol, Katherine A Rauen

Research output: Contribution to journalArticle

42 Citations (Scopus)

Abstract

Background The RASopathies are a class of human genetic syndromes caused by germline mutations in genes that encode protein components of the Ras/mitogen-activated protein kinase (MAPK) pathway. Costello syndrome (CS) is a RASopathy caused by mutations in the HRAS gene, a key regulator of signal transduction. Objective To quantify the specific cutaneous phenotype observed in 46 individuals with Costello syndrome with confirmed HRAS mutations. Methods This was a cross-sectional study. Dermatological surveys were designed by the authors and were completed by parents of mutation-positive individuals with CS at the Costello Syndrome Family Network (CSFN) conferences in 2007 and 2009. Dermatological examinations were performed by the authors at the CSFN conferences. Results Cutaneous papillomas were reported in 33 of the 46 (72%) participants, with age of onset ranging from infancy to 22 years. Individuals with CS are more likely than patients with cardiofaciocutaneous syndrome (CFC) to present with cutaneous papillomas (72% vs. 5%, P < 0·001) and palmoplantar keratoderma (76% vs. 36%, P < 0·001). Individuals with CS are less likely than individuals with CFC to present with sparse or absent eyebrows (9% vs. 90%, P < 0·001) or keratosis pilaris (33% vs. 80%, P = 0·001). This study also identified that loose, redundant skin on the hands and feet, 'stippled' dermatoglyphs (pachydermatoglyphia) on the fingertips (eight of 26, 31%) and acanthosis nigricans (17 of 46, 37%) are frequent features of CS. Conclusions While there is significant phenotypic overlap among syndromes of the Ras/MAPK pathway, individuals with CS are more likely than individuals with CFC syndrome to present with cutaneous papillomas, palmoplantar keratoderma and full eyebrows, and are less likely to present with ulerythema ophryogenes, keratosis pilaris or multiple naevi. The dermatological features of CS, a Ras dysregulation syndrome, share many features with cutaneous paraneoplastic syndromes. This may provide further insight into the role of Ras signalling in cutaneous paraneoplastic syndromes.

Original languageEnglish (US)
Pages (from-to)601-607
Number of pages7
JournalBritish Journal of Dermatology
Volume166
Issue number3
DOIs
StatePublished - Mar 2012
Externally publishedYes

Fingerprint

Costello Syndrome
Phenotype
Skin
Papilloma
Palmoplantar Keratoderma
Eyebrows
Paraneoplastic Syndromes
Mitogen-Activated Protein Kinases
Mutation
Acanthosis Nigricans
Germ-Line Mutation
Nevus
Medical Genetics
Age of Onset
Foot
Signal Transduction

ASJC Scopus subject areas

  • Dermatology

Cite this

Dermatological phenotype in Costello syndrome : Consequences of Ras dysregulation in development. / Siegel, D. H.; Mann, J. A.; Krol, A. L.; Rauen, Katherine A.

In: British Journal of Dermatology, Vol. 166, No. 3, 03.2012, p. 601-607.

Research output: Contribution to journalArticle

@article{e547c58cc6fd40a89628ee22c22dfbc9,
title = "Dermatological phenotype in Costello syndrome: Consequences of Ras dysregulation in development",
abstract = "Background The RASopathies are a class of human genetic syndromes caused by germline mutations in genes that encode protein components of the Ras/mitogen-activated protein kinase (MAPK) pathway. Costello syndrome (CS) is a RASopathy caused by mutations in the HRAS gene, a key regulator of signal transduction. Objective To quantify the specific cutaneous phenotype observed in 46 individuals with Costello syndrome with confirmed HRAS mutations. Methods This was a cross-sectional study. Dermatological surveys were designed by the authors and were completed by parents of mutation-positive individuals with CS at the Costello Syndrome Family Network (CSFN) conferences in 2007 and 2009. Dermatological examinations were performed by the authors at the CSFN conferences. Results Cutaneous papillomas were reported in 33 of the 46 (72{\%}) participants, with age of onset ranging from infancy to 22 years. Individuals with CS are more likely than patients with cardiofaciocutaneous syndrome (CFC) to present with cutaneous papillomas (72{\%} vs. 5{\%}, P < 0·001) and palmoplantar keratoderma (76{\%} vs. 36{\%}, P < 0·001). Individuals with CS are less likely than individuals with CFC to present with sparse or absent eyebrows (9{\%} vs. 90{\%}, P < 0·001) or keratosis pilaris (33{\%} vs. 80{\%}, P = 0·001). This study also identified that loose, redundant skin on the hands and feet, 'stippled' dermatoglyphs (pachydermatoglyphia) on the fingertips (eight of 26, 31{\%}) and acanthosis nigricans (17 of 46, 37{\%}) are frequent features of CS. Conclusions While there is significant phenotypic overlap among syndromes of the Ras/MAPK pathway, individuals with CS are more likely than individuals with CFC syndrome to present with cutaneous papillomas, palmoplantar keratoderma and full eyebrows, and are less likely to present with ulerythema ophryogenes, keratosis pilaris or multiple naevi. The dermatological features of CS, a Ras dysregulation syndrome, share many features with cutaneous paraneoplastic syndromes. This may provide further insight into the role of Ras signalling in cutaneous paraneoplastic syndromes.",
author = "Siegel, {D. H.} and Mann, {J. A.} and Krol, {A. L.} and Rauen, {Katherine A}",
year = "2012",
month = "3",
doi = "10.1111/j.1365-2133.2011.10744.x",
language = "English (US)",
volume = "166",
pages = "601--607",
journal = "British Journal of Dermatology",
issn = "0007-0963",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Dermatological phenotype in Costello syndrome

T2 - Consequences of Ras dysregulation in development

AU - Siegel, D. H.

AU - Mann, J. A.

AU - Krol, A. L.

AU - Rauen, Katherine A

PY - 2012/3

Y1 - 2012/3

N2 - Background The RASopathies are a class of human genetic syndromes caused by germline mutations in genes that encode protein components of the Ras/mitogen-activated protein kinase (MAPK) pathway. Costello syndrome (CS) is a RASopathy caused by mutations in the HRAS gene, a key regulator of signal transduction. Objective To quantify the specific cutaneous phenotype observed in 46 individuals with Costello syndrome with confirmed HRAS mutations. Methods This was a cross-sectional study. Dermatological surveys were designed by the authors and were completed by parents of mutation-positive individuals with CS at the Costello Syndrome Family Network (CSFN) conferences in 2007 and 2009. Dermatological examinations were performed by the authors at the CSFN conferences. Results Cutaneous papillomas were reported in 33 of the 46 (72%) participants, with age of onset ranging from infancy to 22 years. Individuals with CS are more likely than patients with cardiofaciocutaneous syndrome (CFC) to present with cutaneous papillomas (72% vs. 5%, P < 0·001) and palmoplantar keratoderma (76% vs. 36%, P < 0·001). Individuals with CS are less likely than individuals with CFC to present with sparse or absent eyebrows (9% vs. 90%, P < 0·001) or keratosis pilaris (33% vs. 80%, P = 0·001). This study also identified that loose, redundant skin on the hands and feet, 'stippled' dermatoglyphs (pachydermatoglyphia) on the fingertips (eight of 26, 31%) and acanthosis nigricans (17 of 46, 37%) are frequent features of CS. Conclusions While there is significant phenotypic overlap among syndromes of the Ras/MAPK pathway, individuals with CS are more likely than individuals with CFC syndrome to present with cutaneous papillomas, palmoplantar keratoderma and full eyebrows, and are less likely to present with ulerythema ophryogenes, keratosis pilaris or multiple naevi. The dermatological features of CS, a Ras dysregulation syndrome, share many features with cutaneous paraneoplastic syndromes. This may provide further insight into the role of Ras signalling in cutaneous paraneoplastic syndromes.

AB - Background The RASopathies are a class of human genetic syndromes caused by germline mutations in genes that encode protein components of the Ras/mitogen-activated protein kinase (MAPK) pathway. Costello syndrome (CS) is a RASopathy caused by mutations in the HRAS gene, a key regulator of signal transduction. Objective To quantify the specific cutaneous phenotype observed in 46 individuals with Costello syndrome with confirmed HRAS mutations. Methods This was a cross-sectional study. Dermatological surveys were designed by the authors and were completed by parents of mutation-positive individuals with CS at the Costello Syndrome Family Network (CSFN) conferences in 2007 and 2009. Dermatological examinations were performed by the authors at the CSFN conferences. Results Cutaneous papillomas were reported in 33 of the 46 (72%) participants, with age of onset ranging from infancy to 22 years. Individuals with CS are more likely than patients with cardiofaciocutaneous syndrome (CFC) to present with cutaneous papillomas (72% vs. 5%, P < 0·001) and palmoplantar keratoderma (76% vs. 36%, P < 0·001). Individuals with CS are less likely than individuals with CFC to present with sparse or absent eyebrows (9% vs. 90%, P < 0·001) or keratosis pilaris (33% vs. 80%, P = 0·001). This study also identified that loose, redundant skin on the hands and feet, 'stippled' dermatoglyphs (pachydermatoglyphia) on the fingertips (eight of 26, 31%) and acanthosis nigricans (17 of 46, 37%) are frequent features of CS. Conclusions While there is significant phenotypic overlap among syndromes of the Ras/MAPK pathway, individuals with CS are more likely than individuals with CFC syndrome to present with cutaneous papillomas, palmoplantar keratoderma and full eyebrows, and are less likely to present with ulerythema ophryogenes, keratosis pilaris or multiple naevi. The dermatological features of CS, a Ras dysregulation syndrome, share many features with cutaneous paraneoplastic syndromes. This may provide further insight into the role of Ras signalling in cutaneous paraneoplastic syndromes.

UR - http://www.scopus.com/inward/record.url?scp=84857589094&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84857589094&partnerID=8YFLogxK

U2 - 10.1111/j.1365-2133.2011.10744.x

DO - 10.1111/j.1365-2133.2011.10744.x

M3 - Article

C2 - 22098123

AN - SCOPUS:84857589094

VL - 166

SP - 601

EP - 607

JO - British Journal of Dermatology

JF - British Journal of Dermatology

SN - 0007-0963

IS - 3

ER -